Europinidin Mitigates 3-NPA-Induced Huntington’s Disease Symptoms in Rats: A Comprehensive Analysis of Oxidative Stress, Mitochondrial Enzyme Complex Activity, Pro-Inflammatory Markers and Neurotransmitter Alterations

Europinidin Mitigates 3-NPA-Induced Huntington’s Disease Symptoms in Rats: A Comprehensive Analysis of Oxidative Stress, Mitochondrial Enzyme Complex Activity, Pro-Inflammatory Markers and Neurotransmitter Alterations

Huntington’s disease (HD) is a neurodegenerative disease that causes progressive motor and cognitive dysfunction. There is no cure for HD, and current therapeutics can only manage the signs and symptoms as well as slowing disease progression. This investigation examines the possible therapeutic adva...

Full description

Bibliographic Details
Main Author:	Khalid Saad Alharbi
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	Biomedicines
Subjects:	3-nitropropionic acid cognitive dysfunction europinidin Huntington’s disease neurodegenerative diseases antioxidant
Online Access:	https://www.mdpi.com/2227-9059/12/3/625

Similar Items

Europinidin Inhibits Rotenone-Activated Parkinson’s Disease in Rodents by Decreasing Lipid Peroxidation and Inflammatory Cytokines Pathways
by: Ali Altharawi, et al.
Published: (2022-10-01)

Neuroprotectant Effects of Hibiscetin in 3-Nitropropionic Acid-Induced Huntington’s Disease via Subsiding Oxidative Stress and Modulating Monoamine Neurotransmitters in Rats Brain
by: Wael A. Mahdi, et al.
Published: (2023-02-01)

Effect of Shorea robusta resin extract in 3-nitropropionic acid-induced Huntington's disease symptoms in Sprague-Dawley rats
by: Chirag Patel, et al.
Published: (2023-01-01)

Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
by: Jung-Eun Park, et al.
Published: (2013-10-01)

Minocycline in phenotypic models of Huntington's disease
by: Kadiombo Bantubungi, et al.
Published: (2005-02-01)

Anti-Huntington’s Effect of Rosiridin via Oxidative Stress/AchE Inhibition and Modulation of Succinate Dehydrogenase, Nitrite, and BDNF Levels against 3-Nitropropionic Acid in Rodents
by: Muhammad Afzal, et al.
Published: (2022-07-01)

Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington’s disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms
by: Pei Teng Lum, et al.
Published: (2023-07-01)

Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease
by: Maddalena Napolitano, et al.
Published: (2004-03-01)

Ubiquitin-modifying enzymes in Huntington’s disease
by: Karen A. Sap, et al.
Published: (2023-02-01)

Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism
by: Jai Malik, et al.
Published: (2017-01-01)

Protective Effect of Fustin against Huntington’s Disease in 3-Nitropropionic Treated Rats via Downregulation of Oxidative Stress and Alteration in Neurotransmitters and Brain-Derived Neurotrophic Factor Activity
by: May Nasser Bin-Jumah, et al.
Published: (2022-11-01)

Dietary and nutraceutical-based therapeutic approaches to combat the pathogenesis of Huntington’s disease
by: Pradeep Singh, et al.
Published: (2022-05-01)

Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease
by: Shilpa Ramaswamy, et al.
Published: (2007-05-01)

Experience of experimental simulation of Huntington’s disease
by: A. V. Stavrovskaya, et al.
Published: (2017-02-01)

3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future
by: Abel Santamaría, et al.
Published: (2010-02-01)

Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms
by: Marie-Christine Galas, et al.
Published: (2004-02-01)

Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington's disease in rats
by: Navneet Kaur, et al.
Published: (2015-01-01)

Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneurons
by: Barbara Picconi, et al.
Published: (2006-04-01)

Beta-Boswellic Acid Reverses 3-Nitropropionic Acid-Induced Molecular, Mitochondrial, and Histopathological Defects in Experimental Rat Model of Huntington’s Disease
by: Thamer H. Albekairi, et al.
Published: (2022-11-01)

Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition
by: Chia-Lin Wu, et al.
Published: (2010-10-01)

Relevance of mitochondrial alterations in the neurodegenerative diseases, an update and discussion of evidence
by: Carlos F. Aguilar-Gamas, et al.
Published: (2023-10-01)

Strategies to Investigate Ubiquitination in Huntington's Disease
by: Karen A. Sap, et al.
Published: (2020-06-01)

Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF
by: Elena Puerta, et al.
Published: (2010-05-01)

Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila
by: Susanna Campesan, et al.
Published: (2023-09-01)

Huntington’s Disease—An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components
by: Aleksandra S. Taran, et al.
Published: (2020-06-01)

Worsening of Huntington disease phenotype in CB1 receptor knockout mice
by: Stéphane Mievis, et al.
Published: (2011-06-01)

Pathways to decoding the clinical potential of stress response FOXO-interaction networks for Huntington’s disease: of gene prioritization and context dependence
by: Frederic eParmentier, et al.
Published: (2013-06-01)

Swallowing endoscopy findings in Huntington's disease: a case report
by: Thaís Coelho Alves, et al.
Published: (2016-06-01)

Gene Expression Profiling in Huntington’s Disease: Does Comorbidity with Depressive Symptoms Matter?
by: Gabriela Delevati Colpo, et al.
Published: (2020-11-01)

Sleep Disorders in Huntington’s Disease
by: Radoslawa Herzog–Krzywoszanska, et al.
Published: (2019-04-01)

Molecular mechanisms involved in the pathogenesis of Huntington's disease /
by: 506084 Perandones, Claudia, et al.
Published: (c201)

Nrf2 Pathway in Huntington’s Disease (HD): What Is Its Role?
by: Paolo Tucci, et al.
Published: (2022-12-01)

Apoptosis Genes as a Key to Identification of Inverse Comorbidity of Huntington’s Disease and Cancer
by: Elena Yu. Bragina, et al.
Published: (2023-05-01)

Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease
by: Jae K Ryu, et al.
Published: (2004-06-01)

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
by: Sandra Franco-Iborra, et al.
Published: (2018-05-01)

An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid
by: Carmen López-Sánchez, et al.
Published: (2024-02-01)

Neuroprotective effect of silymarin against 3-Nitropropionic acid-induced neurotoxicity in rats
by: Priyanka Chandolia, et al.
Published: (2022-01-01)

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?
by: Simone Migliore, et al.
Published: (2019-04-01)

Major Superficial White Matter Abnormalities in Huntington disease
by: Owen Robert Phillips, et al.
Published: (2016-05-01)

Brain Microbiota in Huntington’s Disease Patients
by: Ruth Alonso, et al.
Published: (2019-11-01)